ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia
04 Octobre 2022 - 07:00AM
ElsMed, Novatec and IBA sign contract to install
radiopharmaceutical production center in Georgia
The center will be equipped with a Cyclone® KIUBE
offering the highest production capacity with a PET cyclotron.
Louvain-La-Neuve, Belgium, October 4,
2022 – IBA (Ion Beam Applications S.A.,
EURONEXT), the world leader in particle accelerator technology and
the world’s leading provider of radiopharmaceutical production
solutions, Novatec International and ElsMed Healthcare Solutions,
the leading Israeli medical-technological company, announced today
that they have signed a contract for the installation of an
integrated radiopharmaceutical production facility in Tbilisi,
Georgia.
The project will be the first of its kind in
Georgia and includes the construction of an ultra-modern
radiopharmaceutical facility equipped with the latest technologies
such as the IBA’s Cyclone® KIUBE and Synthera®+ platform. The
center will produce various types of radiopharmaceutical products
and is expected to start operations in 2024.
The design, construction, operation, and
production processes of the facility will be developed in line with
the International Atomic Energy Agency (IAEA) standards and
recommendations from IBA, as well as meeting set requirements
defined by the legislation of Georgia.
The General Director of Novatec
International, Giorgi Glonti, commented: “This unique
project for an on-site production facility for radiopharmaceutical
compounds will significantly boost the development of nuclear
medicine in the country of Georgia. This initiative will also
contribute to increasing the availability of Positron-Emission
Computed Tomography (PET-CT) for a wider population. The facility
will be able to fully cover the current and future demand of the
Georgian market, both in terms of production and delivery of
fluorodeoxyglucose (18F-FDG) as well as other artificial
radioactive isotopes.”
“Nowadays, radiopharmacies need to produce an
increasing amount of FDG in a limited time frame, in addition to
producing numerous other compounds. The Cyclone® KIUBE is the
perfect solution providing the ability to produce the widest range
of radioisotopes and covers all the needs of PET radiopharmacies,”
said Bruno Scutnaire, President of IBA
RadioPharma Solutions.
Hen Lederman, General Manager of the
ElsMed Healthcare Solutions added: “We are pleased to
participate in a such unique and useful project. Our joint efforts
will have a significantly positive effect in the fight against
cancer in Georgia, with ElsMed being additionally involved in the
facility design and training of necessary personnel, in cooperation
with leading nuclear medicine centers in Israel, and will provide
continuous support until project completion.”
***ENDS***
About Novatec International
Novatec International LLC is a Georgian company
founded to create and develop a radiopharmaceutical production in
order to fulfill Georgia demand for various PET CT isotopes. The
main stakeholders of the Novatec International are well known in
Eastern Europe countries healthcare sector with experience in
establishing a state-of-the-art medical center.
About ElsMed
ElsMed Healthcare Solutions Ltd. is a leading
well-known company providing turnkey solutions including
establishment of complete medical centers worldwide as well as
oncology centers and other various ventures in the medical field
with international standards. The essence of the company’s
operations is to provide the latest and most advanced medical
services to populations worldwide with an active involvement.
The company’s main activities are focused on
establishing, managing and maintaining turnkey medical projects
starting from the development stage through the planning, building,
procurement, technical and medical training as well as routine
operations and mainly after sale ongoing service support. ElsMed
Healthcare Solution has assembled the best and most qualified
professionals in all disciplines: consultants, architects,
engineers, project managers, financial experts, technologists and
medical technicians, physicians, proving track record in the
establishment of medical projects internationally.
Please visit our website for more information:
www.elsmed-healthcare.com
About IBA
IBA (Ion Beam Applications S.A.) is the world
leader in particle accelerator technology. The company is the
leading supplier of equipment and services in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA is also a leading player in the fields
of industrial sterilization, radiopharmaceuticals and dosimetry.
The company, based in Louvain-la-Neuve, Belgium, employs
approximately 1,600 people worldwide. IBA is a certified B
Corporation (B Corp) meeting the highest standards of verified
social and environmental performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).More
information can be found at: www.iba-worldwide.com
CONTACTS
Soumya ChandramouliChief Financial
Officer+32 10 475
890Investorrelations@iba-group.com Olivier
LechienCorporate Communication Director+32 10 475
890communication@iba-group.com |
Consilium Strategic CommunicationsAmber Fennell,
Angela Gray, Lucy Featherstone+44 (0) 20 3709
5700IBA@consilium-comms.com |
- 221004-IBA-Cyclone_KIUBE-Georgia-EN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Nov 2023 à Déc 2023
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Déc 2022 à Déc 2023